Andean Precious Metals (CVE:APM) Shares Up 7.5% – Time to Buy?

Andean Precious Metals Corp. (CVE:APM)’s stock price traded up 7.5% during trading on Thursday . The company traded as high as C$1.29 and last traded at C$1.29. 225,691 shares traded hands during mid-day trading, an increase of 41% from the average session volume of 159,585 shares. The stock had previously closed at C$1.20.

Wall Street Analysts Forecast Growth

Separately, Desjardins upgraded shares of Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.

Andean Precious Metals Stock Performance

The business has a 50 day moving average price of C$1.28 and a 200-day moving average price of C$1.30. The company has a market capitalization of C$192.67 million, a price-to-earnings ratio of 3.39 and a beta of 1.22.

Andean Precious Metals (CVE:APM) last issued its earnings results on Monday, November 11th. The company reported C$0.07 earnings per share for the quarter. Andean Precious Metals had a return on equity of 41.08% and a net margin of 23.75%. As a group, equities analysts predict that Andean Precious Metals Corp. will post 0.3806452 EPS for the current fiscal year.

Insider Activity at Andean Precious Metals

In other news, Senior Officer Juan Carlos Sandoval Amare purchased 31,300 shares of the company’s stock in a transaction that occurred on Friday, January 3rd. The shares were acquired at an average cost of C$1.21 per share, with a total value of C$37,860.48. 69.37% of the stock is owned by corporate insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.